EP
RCEL icon

Essential Partners’s Avita Medical RCEL Stock Holding History

Essential Partners’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79K Sell
433
-212
-33% -$914 ﹤0.01% 2015
2026
Q1 		$2.39K Buy
+645
New +$2.71K ﹤0.01% 1931
2025
Q4 		– Sell
-14
Closed -$72 – 2892
2025
Q3 		$72 Buy
+14
New +$73 ﹤0.01% 2529

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Essential Partners's RCEL Position: Q2 2026 in Review

Essential Partners reduced its Avita Medical (RCEL) stake by 33% in Q2 2026, selling an estimated $914 and leaving 433 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #2015.

Essential Partners first reported a position in RCEL in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.39K in Q1 2026. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Essential Partners held 433 shares of Avita Medical worth $1.79K as of Q2 2026.
  • Essential Partners sold 212 Avita Medical shares in Q2 2026, an estimated $914.
  • Avita Medical made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2015 holding.
  • Essential Partners first reported a position in Avita Medical in Q3 2025 and has held it in 3 quarters since.
  • Essential Partners's Avita Medical position peaked at $2.39K in Q1 2026.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.